We are live on ! Find out more
GMOV

GMO US Value ETF

6 hedge funds and large institutions have $9.04M invested in GMO US Value ETF in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more capital invested

Capital invested by funds: $4.86M → $9.04M (+$4.19M)

2.5% less ownership

Funds ownership: 19.88%17.38% (-2.5%)

14% less funds holding

Funds holding: 76 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HighTower Advisors
1
HighTower Advisors
Illinois
$2.59M +$2.64M +105,418 New
Cerity Partners
2
Cerity Partners
New York
$2.4M
LCWP
3
Legacy Capital Wealth Partners
Arkansas
$1.86M +$1.39M +55,550 +277%
Envestnet Asset Management
4
Envestnet Asset Management
Illinois
$1.04M +$634K +25,331 +147%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$638K +$181K +7,247 +39%
CFG
6
Certior Financial Group
Pennsylvania
$519K +$168K +6,689 +46%
Citadel Advisors
7
Citadel Advisors
Florida
-$732K -29,956 Closed
UBS Group
8
UBS Group
Switzerland
-$15K -615 Closed

GMOV Hedge Fund Activity: Q1 2025 in Review

6 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in GMO US Value ETF (GMOV) for Q1 2025, worth a combined $9.04M — up 86% from $4.86M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of GMOV and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.

The largest buyer was HighTower Advisors, opening a new position worth an estimated $2.64M. The largest seller was Citadel Advisors, exiting entirely with an estimated $732K sold.

  • 6 institutional investors held GMO US Value ETF (GMOV) as of Q1 2025, down from 7 in Q4 2024.
  • Funds reported $9.04M of GMO US Value ETF stock for Q1 2025, up 86% quarter-over-quarter.
  • 1 fund opened new GMO US Value ETF positions in Q1 2025 and 2 closed out, a net change of -1 holder.
  • The largest GMO US Value ETF buyer in Q1 2025 was HighTower Advisors, an estimated $2.64M added.
  • The largest GMO US Value ETF seller in Q1 2025 was Citadel Advisors, an estimated $732K sold.

Based on aggregated 13F filings for Q1 2025.